Skip to main content
Log in

Daclatasvir/sofosbuvir

Reactivation of Hepatitis B Virus: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Zacharakis G, et al. Reactivation of hepatitis b virus during treatment of hepatitis C genotype 3 with daclatasvir and sofosbuvir in a patient with dual infection of hepatitis B and hepatitis C virus. Hepatitis Monthly 18: e12531, No. 1, 20 Jan 2018. Available from: URL: http://doi.org/10.5812/hepatmon.12531 -Cyprus

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Daclatasvir/sofosbuvir. Reactions Weekly 1697, 134 (2018). https://doi.org/10.1007/s40278-018-44690-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44690-9

Navigation